ETF Holdings Breakdown of MLAB

Stock NameMesa Laboratories Inc
TickerMLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS59064R1095
LEI549300ZCG738WLX8ZW79

News associated with MLAB

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,850 shares of the medical instruments supplier’s stock after selling 9,723 shares during the […] - 2025-05-09 08:02:47
Short Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Rises By 20.1%
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average trading volume of 44,100 shares, the short-interest ratio […] - 2025-05-05 08:30:49
Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Decreased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,927 shares of the medical instruments supplier’s stock after selling 577 shares during the quarter. […] - 2025-04-30 08:44:12
Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during […] - 2025-02-11 08:46:52
Mesa Laboratories (NASDAQ:MLAB) Shares Up 12.3% After Better-Than-Expected Earnings
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price was up 12.3% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $143.94 and last traded at $150.43. Approximately 4,303 shares changed hands during trading, a decline of 85% from the average daily volume […] - 2025-02-06 06:08:53
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High After Earnings Beat
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price reached a new 52-week high on Wednesday following a stronger than expected earnings report. The company traded as high as $152.75 and last traded at $137.27, with a volume of 68479 shares traded. The stock had previously closed at $133.93. The medical instruments supplier reported […] - 2025-02-05 06:40:49

MLAB institutional holdings

The following institutional investment holdings of MLAB have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 5,495USD 689,842
2025-05-08 IE00BYZK4552 (iShares Automation & Robotics UCITS ETF USD (Acc)) 14,459USD 1,815,183
2025-05-08 IE00BYWZ0333 (iShares Automation & Robotics UCITS ETF USD (Dist)) 14,459USD 1,815,183
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 535USD 67,164
2025-05-08 IE00BKTLJB70 (iShares Smart City Infrastructure UCITS ETF USD (Dist)) 3,910USD 490,861
2025-05-08 IE00BKTLJC87 (iShares Smart City Infrastructure UCITS ETF USD (Acc)) 3,910USD 490,861 4.2%
Total =42,768 USD 5,369,094
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.